Category: Prostate Cancer

An essential part of planning treatment for prostate cancer (PCa) is determining its size and location. Where and how big is it? If the tumor is found early when it is small and contained within the gland, it is called localized. In this case, the patient is a candidate for a local treatment with curative keep reading

When a patient is told, “You have prostate cancer,” it’s not a simple one-size-fits-all diagnosis. The doctor will then give the patient an idea of how severe his cancer is. If his prostate cancer (PCa) is still localized (that is, contained within the gland), the doctor will specify if it is low, intermediate, or high keep reading

The strategy of using active surveillance (AS) is increasingly recommended to low-risk prostate cancer (PCa) patients as a way to avoid or delay overtreatment. This is a new way of thinking; before the New Millennium, PCa was assumed to be multi-focal and most men with more than 10 years of life expectancy were hurried into surgery or radiation. Today’s terminology includes words that might have been meaningless a decade ago, e.g. indolent cancer, very low risk disease, and focal disease are all consistent with the growing movement toward AS. keep reading

We’ve said it before and we’ll say it again: exercise offers better outcomes for prostate cancer patients. This time, we’re basing our advice on an exciting development in the field of cancer research. Oncology, or the medical specialty dealing with cancer, is increasingly interested in the relationship between exercise and cancer survival. A noted authority keep reading

Once a popular prostate cancer treatment, brachytherapy has seen a sharp decline—and new research may reveal why. A study found that half of patients experienced cancer recurrence, challenging its long-term effectiveness. With evolving treatment options, it’s crucial to weigh the risks and benefits before choosing a path... keep reading

Radiation for prostate cancer can come with long-term sexual side effects that aren’t always discussed upfront. While erectile dysfunction is well known, new research highlights issues with ejaculation, including reduced volume and discomfort. Patients deserve full transparency about these risks before choosing treatment. Learn why informed decision-making is crucial. keep reading

For men considering SBRT for prostate cancer, new research offers good news—this advanced radiation therapy not only reduces side effects but also lowers the risk of secondary cancers. With its targeted approach, SBRT is less likely to lead to the kind of side effects that reduce quality of life after treatment, compared to other methods of radiation treatment. keep reading

Your internal clock does more than regulate sleep—it plays a crucial role in prostate health. Research links circadian rhythm disruption to increased prostate cancer risk by affecting immune function and gene regulation. Whether it’s shift work, aging, or lifestyle habits, preserving your natural sleep cycle could be a key step in prevention. keep reading

New research reveals that liquid biomarkers—measured through simple blood and urine tests—are revolutionizing prostate cancer care. By detecting disease progression early, they help prevent overtreatment and ensure timely, targeted therapies for metastatic cases. Discover how these cutting-edge tests are reshaping prostate cancer care. keep reading

We’ve posted numerous blogs on the contributions of Artificial Intelligence (AI) to various aspects of MRI detection and diagnosis of prostate cancer (PCa). We’ve reported AI’s ability to predict metastasis, assign Gleason scores and PI-RADS scores, pinpoint tumor margins for focal therapy, rule out need for biopsy, predict PCa metastasis, and more—showing the accuracy and keep reading